September 7, 2022 UVA Health to Expand Job-Training Program With $50,000 From Truist Foundation 

UVA Health has received a $50,000 grant from Truist Foundation to expand its “Earn While You Learn” program, which provides local residents with paid, on-the-job training to jumpstart a healthcare career.

September 6, 2022 Frequency of Premenstrual Anxiety, Mood Swings a Public Health Issue, Study Finds

Premenstrual mood swings and anxiety are so common – experienced by more than 64% of women– that they represent a…

September 1, 2022 Data on Cancer Risk From Hormone Therapy ‘Reassuring,’ Menopause Experts Say

A new scientific paper and other recent evidence offer important context about the risk of breast cancer from hormone therapy to treat menopause symptoms, two School of Medicine menopause experts say.

August 30, 2022 Gut Discovery Could Have Big Benefits for Human Health

A new discovery about how the microbes in our gut regulate the body’s biological clock could benefit everything from jet lag to chemo.

August 29, 2022 UVA Health, Community Partners Expand At-Home Patient Monitoring

To make it easier for patients in rural areas of Virginia to access care, UVA Health is teaming with six community health organizations.

August 24, 2022 Organ-Development Discovery to Boost Battle Against Cancer

A new discovery from the School of Medicine reveals a critical process that detetermines how our lungs, liver and digestive tract form.

August 23, 2022 Babur B. Lateef, MD, Appointed Health System Board Chair

Lateef is a board-certified ophthalmologist and prominent physician in Northern Virginia.

August 17, 2022 UVA Creates Potent New Tool to Advance Medical Research

The tool will benefit essentially every area of biomedical research, including the battle against cancer, Alzheimer’s and other diseases.

August 17, 2022 Top Breast Reconstruction Expert to Chair 
UVA’s Department of Plastic and Maxillofacial Surgery

The School of Medicine has recruited internationally recognized plastic surgeon Scott T. Hollenbeck, MD, FACS.

August 11, 2022 Eczema Treatment Cuts Risk of Death From COVID-19

A monoclonal antibody used to treat asthma and eczema can improve survival for patients with moderate to severe COVID-19, a clinical trial at UVA Health suggests.